Key result
Daily 30-minute transcutaneous auricular vagus nerve stimulation for 27 days effectively inhibited the development of nociceptive hypersensitivity in Zucker diabetic fatty rats.
Why the study?
Does daily 30-min taVNS inhibit the development of diabetic neuropathy in Zucker diabetic fatty rats?
Population
Zucker diabetic fatty (fa/fa) rats
Design
Preclinical
Follow-up
27 days
Authors
Loading...
taVNS attenuates diabetic neuropathy in rats; hypothesis-generating for human translation, no practice change yet.
Does daily 30-min taVNS inhibit the development of diabetic neuropathy in Zucker diabetic fatty rats?
Daily taVNS lessens diabetic neuropathy development by enhancing serotonergic function in genetically diabetes-prone individuals.
Li et al. (2018) studied Diabetic neuropathy. Transcutaneous auricular vagus nerve stimulation (taVNS) was evaluated on Development of nociceptive hypersensitivity (thermal hyperalgesia and mechanical allodynia). Daily 30-minute transcutaneous auricular vagus nerve stimulation for 27 days effectively inhibited the development of nociceptive hypersensitivity in Zucker diabetic fatty rats.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: